Aspen signs HIV med deal
Wednesday, April 04, 2007
Tibotec Pharmaceuticals Ltd. Of Ireland on Wednesday announced that it has signed a royalty-free, non-exclusive license agreement with the South African company Aspen Pharmacare.
According to a press release from the two companies, Aspen will register, package and distribute the protease inhibitor PREZISTA (darunavir, DRV) in sub-Saharan Africa.
Source: Health24.com
Wednesday, April 4, 2007
Subscribe to:
Posts (Atom)
THE FISTULA FOUNDATION
